stockportfolio.pro
Stocks / INDV vs SHC
INDV vs SHC
Indivior Pharmaceuticals, Inc. and Sotera Health Company side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
| Indivior Pharmaceuticals, Inc. (INDV) | Sotera Health Company (SHC) | |
|---|---|---|
| Market cap | $4.5B | $4.7B |
| Revenue (latest FY) | $1.24B | $1.16B |
| Net income (latest FY) | $210.00M | $77.95M |
| Revenue growth (5y CAGR) | 11.2% | 7.3% |
| Net margin | 16.9% | 6.7% |
| Return on equity | -214.3% | 12.9% |
| P/E ratio | 19.5 | 39.9 |
| Dividend yield | — | — |
| Profitable years (of last 10) | 2 | 4 |
| Positive free cash flow | No | Yes |
Compare them properly — statement by statement
Open either company interactively: 19 years of income statement, balance sheet and cash flow, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open INDV — free Open SHC — freeFrequently asked questions
Which is bigger, INDV or SHC?
Sotera Health Company is larger by market capitalization — $4.7B versus $4.5B.
Which grows faster, INDV or SHC?
Over the last five fiscal years, Indivior Pharmaceuticals, Inc. grew revenue faster — 11.2%/yr versus 7.3%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.